Ledger.Open graph →
SEC Form D · filed February 28, 2023

Causeway Therapeutics Ltd

Offering
$14.3M
Sold
$14.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLASGOW, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Neil Gibson · Dallas, TXDirectorChristopher Jones · Carrollton, TXDirectorGregor Caldow · Glasgow, United KingdomDirectorNeal Millar · Glasgow, United KingdomExecDavid Armour · Glasgow, United KingdomExecDeclan Doogan · Stonington, CTDirectorAlexander Picket · Glasgow, United KingdomDirectorDerek Gilchrist · Glasgow, United KingdomExec · DirectorChristopher Jones · San Carlos, CADirectorNeil Gibson · San Diego, CA 92121, CADirectorGregor Caldow · Glasgow, United KingdomDirectorNeal Millar · Glasgow, United KingdomExecDavid Armour · Glasgow, United KingdomExecDeclan Doogan · New Haven, CTDirectorAlexander Picket · Glasgow, United KingdomDirectorDerek Gilchrist · Glasgow, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗